PBFE Rabbit Polyclonal Antibody

Catalytic activity: (3S) -3-hydroxyacyl-CoA = trans-2 (or 3) -enoyl-CoA + H (2) O., catalytic activity: (3Z) -dodec-3-enoyl-CoA = (2E) -dodec-2-enoyl-CoA., catalytic activity: (S) -3-hydroxyacyl-CoA + NAD (+) = 3-oxoacyl-CoA + NADH., disease:Absent in patients suffering with peroxisomal disorders such as Zellweger syndrome, neonatal adrenoleukodystrophy and infantile Refsum disease., pathway:Lipid metabolism; fatty acid beta-oxidation., similarity:In the C-terminal section; belongs to the 3-hydroxyacyl-CoA dehydrogenase family., similarity:In the N-terminal section; belongs to the enoyl-CoA hydratase/isomerase family., subunit:Monomer., tissue specificity:Liver and kidney. Lower amounts seen in the brain., catalytic activity: (3S) -3-hydroxyacyl-CoA = trans-2 (or 3) -enoyl-CoA + H (2) O., catalytic activity: (3Z) -dodec-3-enoyl-CoA = (2E) -dodec-2-enoyl-CoA., catalytic activity: (S) -3-hydroxyacyl-CoA + NAD (+) = 3-oxoacyl-CoA + NADH., disease:Absent in patients suffering with peroxisomal disorders such as Zellweger syndrome, neonatal adrenoleukodystrophy and infantile Refsum disease., pathway:Lipid metabolism; fatty acid beta-oxidation., similarity:In the C-terminal section; belongs to the 3-hydroxyacyl-CoA dehydrogenase family., similarity:In the N-terminal section; belongs to the enoyl-CoA hydratase/isomerase family., subunit:Monomer., tissue specificity:Liver and kidney. Lower amounts seen in the brain.

Fatty acid metabolism; Valine; leucine and isoleucine degradation; Lysine degradation; Tryptophan metabolism; beta-Alanine metabolism; Propanoate metabolism; Butanoate metabolism; Limonene and pinene degradation; PPAR